Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Colorado Considers Psilocybin Prescription Legislation

LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug ...

DEA Schedules Cannabis Rescheduling Hearings for Early 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has outlined a schedule for witness testimony in the ongoing hearing concerning the potential reclassification of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney ...

Week’s In Review: Ohio Legislature Considers Ban on Intoxicating Hemp Products; Florida’s Cannabis Legalization Measure Fails Despite Majority Support; Climate First Bank Introduces Cannabis-Focused Financial Services in Florida; DEA Postpones Cannabis Rescheduling Hearings to 2025

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

  • CanPay

Worried About IRS Audits? What You Need to Know

LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market ...

  • CBD Oil Market, CBD Skin Care Market, Industrial hemp Market, Medical Marijuana Market, Cannabis Market, Legalized Cannabis Market

MariMed Reports Second Quarter 2022 Earnings

NORWOOD - MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2022. “We executed on our ...

  • Financial Result, cannabis sales, Cannabis Cultivation Market

Curaleaf Reports Second Quarter 2022 Results

WAKEFIELD, Mass. - Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the second quarter ended ...

Subscribe To Our Newsletter

Go to Top